Web Analytics

3 Latest Announced Rounds

  • $4,300,000
    Seed

    2 Investors

    Software Development
    Oct 21st, 2025
  • $25,000,000
    Unknown

    5 Investors

    Biotechnology Research
    Oct 21st, 2025
  • $6,500,000
    Seed

    1 Investors

    Fundraising
    Oct 21st, 2025
$1,536.40M Raised in 63 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Delphia Therapeutics

start up
United States - Cambridge, Massachusetts
  • 07/05/2024
  • Series A
  • $67,000,000

Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.


Related People

Kevin MarksFounder

Kevin Marks United States - Cambridge, Massachusetts

N/A